β(1)-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart Failure

β(1)受体阻滞剂增强慢性心力衰竭中内源性儿茶酚胺的正性肌力作用

阅读:1

Abstract

Although β(1)-blockers impressively reduce mortality in chronic heart failure (CHF), there are concerns about negative inotropic effects and worsening of hemodynamics in acute decompensated heart failure. May receptor theory dispel these concerns and confirm clinical practice to use β(1)-blockers? In CHF, concentrations of catecholamines at the β(1)-adrenoceptors usually exceed their dissociation constants (K (D)s). The homodimeric β(1)-adrenoceptors have a receptor reserve and display negative cooperativity. We considered the binomial distribution of occupied receptor dimers with respect to the interaction of an exogenous β(1)-blocker and elevated endogenous agonist concentrations > [K (D)s], corresponding to an elevated sympathetic tone. Modeling based on binomial distribution suggests that despite the presence of a low concentration of the antagonist, the activation of the dimer receptors is higher than that in its absence. Obviously, the antagonist improves the ratio of the dimer receptors with only single agonist activation compared with the dimer receptors with double activation. This leads to increased positive inotropic effects of endogenous catecholamines due to a β(1)-blocker. To understand the positive inotropic sequels of β(1)-blockers in CHF is clinically relevant. This article may help to eliminate the skepticism of clinicians about the use of β(1)-blockers because of their supposed negative inotropic effect, since, on the contrary, a positive inotropic effect can be expected for receptor-theoretical reasons.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。